A short peptide bioregulator (Khavinson) aimed at lung/bronchial tissue. The idea behind these tissue-specific bioregulators is to support the gene activity of a particular organ, here, the respiratory tract; in brief courses.
Research referenceCommunity compiled
i
Research & reference information
This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.
Overview
A short peptide bioregulator (Khavinson) aimed at lung/bronchial tissue.
The idea behind these tissue-specific bioregulators is to support the gene activity of a particular organ, here, the respiratory tract; in brief courses.
What It Does
Bronchogen is a Khavinson tetrapeptide (Ala-Glu-Asp-Leu, AEDL) targeting bronchial/respiratory tissue.
Like other peptide bioregulators, it is proposed to normalize tissue-specific gene expression and support repair in its target organ.
Evidence is largely from Russian research; used in short pulsed courses.
Reconstitution
Vial Size
BAC Water / Solvent
Concentration
20 mg
+ 4 mL
5 mg/mL
Interactive tool
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Calculated concentration—Enter both values above.
Optional conversion
Enter a target amount you already have and select the syringe capacity.
Calculated draw—Enter concentration inputs and a target amount.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
any time. Note: respiratory-targeted bioregulator; evidence is largely Russian research, limited Western RCTs.
Population Considerations
Unisex peptide bioregulator, short courses, no sex-specific dosing; minimal human data. Avoid in pregnancy.
Handling & Stacking
Injection site
SubQ, abdomen. Rotate.
Storage
Freeze-dried: -4°F. Reconstituted: 36–46°F, best used within ~4–6 weeks (structure-based estimate), which covers the usual course.
Side effects
Generally well tolerated, mild injection-site reaction. Human safety data limited.
What to expect
Proposed respiratory-tissue support over a course; subtle, and evidence is preliminary. Supply math 20mg → 2 vials (20-day course @ 2 mg/day SubQ)
Pairs well with
Other Khavinson bioregulators (organ-specific stacks); Thymalin (immune); Epithalon (longevity)
Avoid
Active malignancy of the target tissue (bioregulator gene-expression effects, theoretical). Pregnancy
Safety & Patient Education
Contraindications
Active malignancy (theoretical, tissue gene-expression modulation) Pregnancy and lactation Hypersensitivity to the peptide
Warnings
Limited Western clinical data, most evidence is Russian research Quality varies, request a COA Subtle, course-based effects; not an acute therapy
Drug interactions
No well-characterized interactions Commonly stacked with other bioregulators in a course
Labs
None compound-specific; respiratory function tracking if that’s the goal
Stop criteria
Persistent injection-site reaction Any unexpected respiratory or systemic symptom Pregnancy
Patient education
A short-course, organ-targeted bioregulator; not continuous Evidence is preliminary and largely Russian Subtle effects; manage expectations Request a COA; source quality matters
Standard Labs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
